Clinical features of idiopathic restless legs syndrome in Japanese patients

Clinical Neurology

Volumn 50, Issue 6, 2010, Pages 385-392

  Kume, Akito ^a,b   Kume, Hideaki ^a  

^a Kume Clinic   (Japan)

^b Nagoya Clinical Neuropharmacology Laboratory   (Japan)

Author keywords

Dopamine agonist; Neurological examination; Periodic limb movement; Restless legs syndrome; Unpleasant sensation

Indexed keywords

CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN;

ADULT; ALGORITHM; ARTICLE; CLINICAL FEATURE; CONSULTATION; DOPAMINERGIC ACTIVITY; DRUG EFFICACY; FAMILY HISTORY; FEMALE; HIP DISEASE; HUMAN; IDIOPATHIC DISEASE; IMMOBILIZATION; INSOMNIA; ISCHIALGIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; MOOD; NEUROLOGIC EXAMINATION; NEUROLOGY; OUTPATIENT DEPARTMENT; PERIODIC LIMB MOVEMENT DISORDER; PHYSICIAN; PRURITUS; RADICULOPATHY; REMISSION; RESTLESS LEGS SYNDROME; SPINAL CORD DISEASE; SYMPTOM; UNPLEASANT SENSATION; VALIDITY; WORK CAPACITY;

EID: 77954414519     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.50.385     Document Type: Article

References (30)

1. Ekbom KA. Restless legs. Acta Med Scand 1945;158(Suppl):1-123.
2. Hening W, Walters AS, Allen RP, et al. Impact diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-246.
3. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact REST general population study. Arch Intern Med 2005;165:1286-1292.
4. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003;4:101-119.
5. Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65. (Pubitemid 27032881)
6. Mizuno S, Miyaoka T, Inagaki T, et al. Prevalence of restless legs syndrome in non-institutionalized Japanese elderly. Psychiatry Clin Neurosci 2005;59:461-465. (Pubitemid 41139555)
7. Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004;79:916-922. (Pubitemid 38879959)
8. Kume A, Sato H, Nonomura H, et al. An intradialysis diagnostic test for restless legs syndrome. A pilot study. Am J Kidney Dis 2009;54:318-326.
9. Zucconi M, Ferri R, Allen R, et al. The official world association of sleep medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the international restless legs syndrome study group (IRLSSG). Sleep Med 2006;7:175-183.
10. Benes H, Walters AS, Allen RP, et al. Definition of restless legs syndrome, how to diagnose it and how to differentiate it from RLS mimics. Mov Disord 2007;22 (Suppl 18):S401-S408.
11. restless legs syndrome. Brain Nerve 2009;61:539-547.
12. Buchfuhrer MJ, Hening WA, Kushida CA. Restless legs syndrome Coping with your sleepless nights. New York: Demos Medical Publishing; 2007. p. 45-66.
13. The Internatioal Restless Legs Syndrome Study Group. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132.
14. Kohnen R, Allen RP, Benes H, et al. Assessment of restless legs syndrome. Methodological approaches for use in practice and clinical trials. Mov Disord 2007;22 (Suppl 18):S485-S494.
15. Garcia-Borreguero D, Allen RP, Kohnen R, et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a world association of sleep medicine - International restless legs syndrome study group consensus conference at the Max Plank Institute. Sleep Med 2007;8:520-530.
16. Berger K. Leudemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196-202.
17. Whittom S, Dauvilliers Y, Pennestri M-H, et al. Age-atonset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med 2007;9:54-59.
18. Benes H, Heinrich CR, Ueberall MA, et al. Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep 2004;27:674-682.
19. Ekbom KA. Restless legs syndrome. Neurology 1960;10:868-873.
20. Tan EK, Seah A, See SJ, et al. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001;16:577-579.
21. Lee HB, Hening WA, Allen RP, et al. Race and restless legs syndrome symptoms in an adult community sample in east Baltimore. Sleep Med 2006;7:642-645.
22. O'Brien LM, Holbrook CR, Jones VF, et al. Ethnic difference in periodic limb movements in children. Sleep Med 2007;8:240-246.
23. Merlino G, Valente M, Serafini A, et al. Restless legs syndrome: diagnosis, epidemiology, classification and consequences. Neuro Sci 2007;28:S37-S46.
24. Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 2004;26:925-935.
25. Hening WA, Allen RP, Chaudhuri KR, et al. Clinical significance of RLS. Mov Disord 2007;22 (Suppl 18):S395-S400.
26. Trenkwalder C. Restless legs syndrome. Overdiagnosed or underdiagnosed? Nat Clin Pract Neurol 2007;3:474-475.
27. Benes H, Kohnen R. Validity of the essential criteria and additional clinical features for the diagnosis of restless legs syndrome. Sleep Med 2005;6 (Suppl 2):S155 (abstr).